Company Filing History:
1 out of 1 
1 out of 43 Years Active: 2007-2012
Title: Aihua Nie: Innovator in Neurodegenerative Disease Research
Introduction
Aihua Nie is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmacology, particularly in the development of compounds aimed at treating neurodegenerative diseases. With a total of two patents to his name, his work focuses on innovative solutions for complex medical challenges.
Latest Patents
Aihua Nie's latest patents include groundbreaking inventions that address critical health issues. One of his patents is titled "Derivatives of substituted tartaric acid and usage for preparing beta-secretase inhibitors." This invention relates to compounds represented by a specific formula, which are designed to treat chronic neurodegenerative diseases such as Alzheimer's disease. The patent outlines preparation methods for these compounds and their pharmaceutical applications.
Another notable patent is for "Substituted 6-membered N-heterocyclic compounds and method for their use as neurological regulators." This invention involves neurotrophic compounds that serve as inhibitors of FK560 binding proteases activity. These compounds are intended for the treatment and prevention of neurodegenerative diseases and other nerve disorders associated with nerve injuries.
Career Highlights
Aihua Nie has worked at the Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences, PLA China. His experience in this esteemed institution has allowed him to contribute to significant advancements in pharmacological research. His work has been instrumental in developing new therapeutic strategies for neurological conditions.
Collaborations
Aihua Nie has collaborated with notable colleagues, including Song Li and Lili Wang. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation in the field of pharmacology.
Conclusion
Aihua Nie's contributions to the field of neurodegenerative disease research through his innovative patents highlight his role as a key inventor in pharmacology. His work continues to pave the way for new treatments that could significantly impact the lives of those affected by these challenging conditions.